Evidence map›Paper›PMID 42835573›Full record

ArticleJournal of pathology informatics2026

CellPrior-net: Prior-guided nuclei detection and classification for H&E whole-slide images.

Falah Jabar, Pasquale Lombardi, Aria Torkpour, Masoud Tafavvoghi, Per Niklas Benzler Waaler, Sigve Andersen, Erna-Elise Paulsen, Mette Pøhl, Lill-Tove Rasmussen Busund, Tom Donnem and 3 more

Abstract read
In one paragraph

Article in Journal of pathology informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Falah JabarDep. of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.
Pasquale LombardiDep. of Surgery and Cancer, Imperial College London, London, United Kingdom.
Aria TorkpourDep. of Surgery and Cancer, Imperial College London, London, United Kingdom.
Masoud TafavvoghiDepartment of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Per Niklas Benzler WaalerDepartment of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Sigve AndersenDep. of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Erna-Elise PaulsenDep. of Pulmonology, University Hospital of North Norway, Tromsø, Norway.
Mette PøhlDep. of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Lill-Tove Rasmussen BusundDep. of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.
Tom DonnemDep. of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Elin RichardsenDep. of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.
David J PinatoDep. of Surgery and Cancer, Imperial College London, London, United Kingdom.
Mehrdad RakaeeDep. of Cancer Genetics, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate nuclei detection and classification in hematoxylin and eosin (H&E) whole-slide images (WSIs) is a key task in computational pathology, particularly for quantitative analysis of the tumor microenvironment. However, this task remains highly challenging due to variations in nuclei morphology, staining procedures, scanners, organs, magnifications, and WSI artifacts. In addition, many existing pipelines rely on computationally demanding architectures and post-processing procedures, making gigapixel WSI analysis time-consuming. In this work, CellPrior-Net (CP-Net) is proposed, an efficient nuclei detection and classification pipeline that utilizes a lightweight convolutional neural network architecture and hematoxylin (H) channel as prior information to enhance nuclei-aware feature learning. Extensive benchmarking was conducted against state-of-the-art pipelines on eight public and private datasets (total:∼10.4 M nuclei) obtained from different organs, scanners, magnifications, and clinical centers. Experimental results demonstrate that CP-Net achieves comparable performance while significantly reducing inference time. Furthermore, CellQuant-Net was introduced-an end-to-end nuclei quantification pipeline-that integrates a quality assessment model to exclude regions with artifacts, followed by CP-Net cell detection and classification. The pipeline is publicly available on GitHub, and provides a potentially efficient and scalable framework for downstream computational pathology applications.

Indexed as

Computational pathologyComputer visionDeep learningDigital pathologyH&E whole-slide imagesNuclei detection and classification

Identifiers

PMID42835573
PMCPMC13636067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.